Camber Pharmaceuticals is known for its reliability and innovation in the pharmaceutical industry. Supported by its parent company, Hetero, Camber has become a leading provider of generic medications. Hetero made a strategic investment in a vertical integration supply strategy over 30 years ago. With over 1,000 reactors producing more than 300 Active Pharmaceutical Ingredients (APIs) across various therapeutic segments, Hetero plays a crucial role in Camber’s operations.
Camber’s vertical integration covers every step of the manufacturing process, from Research and Development (R&D) to Key Starting Materials (KSMs), APIs, and Finished Dosage Forms (FDFs). This approach helps reduce risks for customers and patients, ensuring consistent quality and reliability.
Camber carefully manages its supply chain, with 12 months of total control. They keep three months of inventory in stock, have two months in transit, spend four months in manufacturing, and stage three months. This meticulous planning ensures that supply service levels consistently exceed 95% for primary positions, guaranteeing patients access to medications.
The benefits of Camber’s vertical integration include a reliable supply of medications, high-quality products, competitive pricing, and excellent service. Patients and customers can trust Camber Pharmaceuticals to provide the medications they need reliably and with consistent quality, thanks to the company’s dedication to excellence and innovation.
